Passage BIO, Inc.·4

May 28, 6:04 PM ET

Yamada Tadataka 4

4 · Passage BIO, Inc. · Filed May 28, 2021

Insider Transaction Report

Form 4
Period: 2021-05-27
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2021-05-27+16,91816,918 total
    Exercise: $13.83Exp: 2031-05-26Common Stock (16,918 underlying)
Footnotes (1)
  • [F1]The stock option vests as of 1/12 of the total shares monthly beginning on June 27, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION